Ovarian Stimulation Clinical Trial
Official title:
Effect of Controlled Ovarian Stimulation With H FSH and HHMg Vs HMG Alone on Oocyte and Embryo Quality in IcsI Patients
Investigate and compare the efficacy of H FSH plus HMG Vs HMG alone on oocyte and embryo quality in IcsI patients
Status | Not yet recruiting |
Enrollment | 70 |
Est. completion date | October 2021 |
Est. primary completion date | September 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 35 Years |
Eligibility |
Inclusion Criteria: 1. Infertil women aged from 20_35yr 2. Normal utreus 3. Normal ovaries 4. unexplained infertility 5. no endometriosis Exclusion Criteria: 1 - poor responders to gonadotropin 2-Prior history of more than 3unsucceful ICSI 3-Any malformation of sexual organs |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Minia University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients | Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients | 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01121991 -
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies
|
Phase 3 | |
Recruiting |
NCT02715336 -
Efficacy and Safety of Medication Used to Stimulate Ovulation
|
Phase 4 | |
Not yet recruiting |
NCT03298750 -
Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve
|
N/A | |
Completed |
NCT03939403 -
Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor
|
Phase 4 | |
Recruiting |
NCT06142708 -
The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
|
N/A | |
Recruiting |
NCT05166668 -
Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
|
N/A | |
Completed |
NCT04549649 -
The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response
|
N/A | |
Terminated |
NCT01816789 -
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
|
Phase 4 | |
Completed |
NCT00823004 -
Antagonist/Letrozole in Poor Responders
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06175832 -
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
|
Phase 4 | |
Completed |
NCT01145144 -
Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment
|
N/A | |
Completed |
NCT00830492 -
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
|
Phase 4 | |
Completed |
NCT01037699 -
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
|
Phase 3 | |
Completed |
NCT00829075 -
Impact of Three Different Gonadotrophin Regimes on Egg Donation Program
|
Phase 4 | |
Completed |
NCT01112358 -
Lutropin Alfa in Women at Risk of Poor Response
|
Phase 2 | |
Recruiting |
NCT03400722 -
Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response
|
Phase 4 | |
Completed |
NCT00669786 -
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
|
Phase 3 |